Risperdal profits trump the $2 billion in criminal penalties

Tuesday, October 6th, 2015 at 2:38 pm    

Johnson & Johnson’s aggressive marketing of the antipsychotic medication Risperdal has caused quite a controversy, especially since they allegedly withheld data about potential side effects such as breast development and stroke.

Upon its initial release in 1994, Johnson & Johnson had a small market for Risperdal, as the Food and Drug Administration said it was not necessarily better than any previous version of antipsychotics, and was targeted specifically for those suffering from schizophrenia . J&J later overhauled Risperdal and branded it as a medicine for a wide range of medical problems. Johnson & Johnson formed ElderCare and prescribed Risperdal even when it was not approved for consumption by the elderly. FDA protested and has reported numerous deaths among the ones who took the drugs.

Johnson & Johnson has profited handsomely from these crimes. Although they were hit with $2 billion in penalties and settlements, J&J has seen $30 billion in Risperdal sales around the world. If you know someone who has been harmed by the side effects brought by Risperdal, you may want to seek legal assistance in order to recover financial compensation. Speak with our experienced legal team at Williams Kherkher by calling us today at (800) 220-9341.

Explosion at Pasadena Chemical Plant Injures Four

Saturday, October 3rd, 2015 at 9:39 am    

An explosion on Friday at a Pasadena, TX chemical plant resulted in injuries to four workers, including one 42-year-old man who was sent via life flight to a nearby hospital to receive treatment for severe chemical burns to his chest and face.

According to authorities, the plant, which was located on the Houston ship channel, manufactures a variety of different chemicals and is owned by Albemarle Corporation. The site is operational seven days a week, and employs 300 workers on site. Authorities reported that there was no risk of chemicals harming those in the nearby community, and as of Friday afternoon, a fire that resulted from the explosion had been put out.

Investigators are still looking into the incident to determine what caused the explosion in the first place. Our team here at Williams Kherkher will continue to monitor this situation and will provide more information as it becomes available.

Possible causes of blood presence in stool

Friday, October 2nd, 2015 at 10:36 am    

People may be terrified when seeing blood in their stool. The mere thought that it could be a sign of a possible problem in the digestive system is alarming. Following are some of the cause of having blood in the stool:

  • Blood can be seen in the stool if the diverticula in the colon are infected
  • People suffering from peptic ulcer
  • People who take high dosages of anti-inflammatory medicines
  • People with colon problems (colitis)
  • People with problems in the esophagus

The kind of blood found in the stool may vary in color depending on the affected part of the internal organ. People who notice blood in their stool are advised to consult their physician to immediately detect the source of the bleeding.

Unfortunately, people who are taking Xarelto medicine to prevent strokes and blood clots may experience serious side effects and may experience blood in their stool. If you are in such situation, a lawyer at Williams Kherkher may possibly help you get treatment funds from negligent pharmaceutical companies. Consult with us today about your situation by calling (800) 220-9341 to learn more of your options.

Proposed Zofran Multidistrict Litigation possibly headed to Pennsylvania

Wednesday, September 23rd, 2015 at 5:10 pm    

Zofran is a popular medication prescribed to address nausea and vomiting, and as such, was prescribed to many women with morning sickness even though it was not approved for use as a morning sickness drug. The result, unfortunately, was that many babies were born with birth defects as a result of exposure to the medication. As a result, many are now taking legal action against the manufacturer, GlaxoSmithKline.

Twelve cases were already filed against the manufacturer last July 2015 with the U.S. Judicial Panel, in order to establish pre-trial proceedings. GlaxoSmithKline said that consolidating all those cases in one court would make for uniform standards and efficiency. Arguments on whether or not to consolidate these cases will begin on October 1, 2015.

All of these cases involve parents with babies born with birth defects such as heart defects, malformations, and cleft lip and palate. The parents have complained that GlaxoSmithKline promoted Zofran as a treatment for morning sickness even when the drug was not tested as such and not approved by the FDA for use in treating morning sickness.

If your child was born with birth defects and you believe that it is due to exposure to Zofran before the child was born, the help of an experienced attorney can be an invaluable asset. Contact the Zofran attorneys of Williams Kherkher today at (800) 220-9341 for the dedicated legal assistance you need.

Possible complications linked to intracerebral hemorrhage

Wednesday, September 23rd, 2015 at 10:51 am    

People who have intracerebral hemorrhage are at risk of suffering from other complications depending on the duration of oxygen deprivation to the brain and the area of the brain where the hemorrhage takes place. Complications include:

  • Loss of eye sight
  • Seizures
  • Sensory and locomotion problems afflicting half of the person’s body
  • Brain and psychological problems including depression and cognitive problems
  • Eating and speaking problems
  • Fatigue
  • Pneumonia

People who have intracerebral hemorrhage are advised to immediately seek medical treatment to avoid the following complications that are often serious in nature.

The pharmaceutical legal team of Williams Kherkher understands that many families have to deal with great financial loss after their loved ones suffer from intracerebral hemorrhage. However, if this happens to you or to a loved one, we may possibly work on your behalf if your medical condition is a result of taking Xarelto medicine. Call our office today at (800) 220-9341 to learn more of your options.

Ovarian cancer patients taking beta-blockers have better survival rates

Tuesday, September 22nd, 2015 at 4:44 pm    

A retrospective study found that ovarian cancer patients who took certain types of drugs for hypertension had better survival rates than other women with the disease, an article from WebMD reported.

In a study of 1,425 cancer patients taking beta-blockers, scientists learned that women taking beta-2 and beta-3 blockers, or nonselective beta-blockers, lived for almost eight years on average after an ovarian cancer diagnosis, as compared to three years among those who did not take beta-blockers. According to research, beta-blockers are known to inhibit the effects of epinephrine, which promotes the growth of cancer cells.

However, a researcher at the U.S. National Cancer Institute, Dr. Christina Annuziata, warned ovarian cancer patients about the dangers of using beta-blockers when you don’t have high blood pressure.

The use of power morcellators during hysterectomies may spread undetected cancer tissues in the inside lining of the uterus, resulting in ovarian cancer. To know more about holding the device makers accountable for all of your damages, seek the legal guidance and representation of our legal team at Williams Kherkher. Call us at (800) 220-9341 for a free case assessment today.

Transposition of great arteries: What it is and its symptoms

Tuesday, September 22nd, 2015 at 4:36 pm    

Transposition of great arteries (TGA) is a critical congenital heart anomaly that occurs when the two main blood vessels that carry blood out of the heart, the aorta and the pulmonary artery, are transposed. Because this condition is fatal, babies with TGA are required to undergo corrective surgery a few days after their birth.

In TGA, oxygen-rich blood goes back to the lungs via the pulmonary artery without going out into the different parts of the body. The oxygen-depleted blood, on the other hand, enters the heart, bypasses the lungs, and goes out of the heart and into the different parts of the body via the aorta. This medical condition causes the organs to be deprived of the oxygen they need. TGA can be detected via fetal ultrasound during pregnancy. Hours after birth, doctors may tell if a baby is suffering from TGA due to cyanosis, or bluish discoloration of the skin.

TGA is just one of the many congenital heart defects associated with the use of anti-nausea drug Zofran among pregnant women suffering from morning sickness. If you believe taking this drug has caused your baby to suffer undue harm, our legal team at Williams Kherkher might be able to fight on your behalf in a legal claim against the pharmaceutical company involved. Call us at (800) 220-9341 and tell us more about your situation today.

Multi-billion dollar trial over Takeda’s Actos begins

Tuesday, September 22nd, 2015 at 2:59 pm    

Lawyers of two plaintiffs are planning to seek a $2 billion verdict in a trial against Japanese pharmaceutical giant Takeda over allegations that the company failed to inform patients and medical professionals about the risk that their drug, Actos, poses by potentially causing bladder cancer.

The trial involves two cases of men who developed bladder cancer after using the diabetes drug. One of the cases was filed in November 2013 by Mary Iorio, the widow of Maurice Iorio, who died due to complications from bladder cancer. Iorio’s case was consolidated with a related case filed by George Decou in June 2013.

During opening statements in the trial, one lawyer stated how the pharmaceutical company deliberately obliterated hard drives of eight company officials after being asked to keep the data they contained.

Pharmaceutical companies who press for economic gains at the expense of consumer safety should be held liable to the fullest extent permitted by the law. We at Williams Kherkher can guide you through the process of filing a claim if you have been harmed by a dangerous drug such as Actos. Call us at (800) 220-9341 today.

Research shows pancreatitis increases diabetes risk

Tuesday, September 22nd, 2015 at 2:28 pm    

The correlation between pancreatitis and diabetes mellitus has once again been confirmed by new research, but with a twist – scientists have found that the risk of developing diabetes is much more severe for those with pancreatitis, and visa-versa.

The study involved 127 patients who have suffered and survived from a pancreatitis attack. Of the 127 participants, 28 of them developed diabetes either during index admission or during the course of the follow up. Researchers further found that patients with more severe pancreatitis attacks were at higher risk of developing diabetes.

Risperdal is known to overactivate the parathyroid gland, which in turn may increase calcium and phosphorus levels in the bloodstream. Too much calcium in the bloodstream may cause the lining of your pancreas to become inflammed, causing pancreatitis. Our legal team at Williams Kherkher is willing shed light on your inquiries about obtain financial compensation through a lawsuit if you have been harmed by this drug in any way. Call us at (800) 220-9341 today.

Williams Kherkher files lawsuit against Olympus over power morcellator

Monday, September 21st, 2015 at 3:16 pm    

Williams Kherkher is representing a Pennsylvania woman who is now the third person to file suit against the Olympus manufacturing company responsible for the PKS PlasmaSORD Bipolar Morcellator after the machine was found to have caused the spread of uterine cancer. The complaint, along with the two existing complaints, claims that Olympus either knew or should have known that the power morcellator could potentially cause the spread of undetected cancer cells during gynecological surgery.

The device was approved under a 501(k) by the U.S. Food and Drug Administration several decades ago, as it was “substantially equivalent” to previously approved technology and therefore allowed to bypass testing. The morcellator uses cutting jaws to remove tissue laparoscopically, and has caused damage by cutting through uterine fibroids that contained cancerous cells, allowing them to propagate throughout the abdomen and pelvis. The consequences are an increased rate of cancerous growth and a worsened prognosis.

The FDA eventually recognized the risks associated with these devices and published a safety warning regarding the potential danger of power morcellator use during hysterectomies and myomectomies. In response to numerous lawsuits, Johnson and Johnson voluntarily recalled all of their power morcellators in 2014. Other makers, however, have threatened to pursue legal action against individuals or parties who denounce their product.

1 2 3 48
The Search Engine Guys